<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02291601</url>
  </required_header>
  <id_info>
    <org_study_id>R13-052</org_study_id>
    <nct_id>NCT02291601</nct_id>
  </id_info>
  <brief_title>Preoperative CHG Cloth (2)</brief_title>
  <official_title>Assessment of the Antimicrobial Efficacy of 2% CHG Cloth Preoperative Skin Preparation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medline Industries</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medline Industries</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Demonstrate the reduction of bacteria on the skin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Examine the antimicrobial cloth effects on bacteria of the abdomen and groin area.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Count the number of bacteria on skin</measure>
    <time_frame>10 minutes to 8 hours</time_frame>
    <description>Bacteria on the skin will be evaluated at time 0, 10 minutes, 6 hours and 8 hours after treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the side effects on the skin</measure>
    <time_frame>10 min to 8 hours</time_frame>
    <description>Treated skin will be assessed for any irritation.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">879</enrollment>
  <condition>Surgical Skin Preparation</condition>
  <arm_group>
    <arm_group_label>Chlorhexidine Gluconate Cloth</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2% CHG, single application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vehicle Cloth</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Excipients on cloth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Chlorhexidine gluconate solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dynahex 2% CHG</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine Gluconate</intervention_name>
    <description>comparison with other CHG products</description>
    <arm_group_label>Chlorhexidine Gluconate Cloth</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vehicle</intervention_name>
    <description>Cloth with Excipients no CHG</description>
    <arm_group_label>Vehicle Cloth</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% Chlorhexidine Gluconate Solution</intervention_name>
    <description>CHG solution</description>
    <arm_group_label>Active Chlorhexidine gluconate solution</arm_group_label>
    <other_name>DynaHex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or Females

          -  16 years of age or older

          -  Signed informed consent

          -  Good Health

          -  Six inches of abdomen and groin areas without tattoos, or skin disorders

        Exclusion Criteria:

          -  Dermatological Conditions

          -  Sensitivity to latex

          -  Sensitivity to CHG
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>C Beausoleil</last_name>
    <role>Principal Investigator</role>
    <affiliation>BS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BioScience</name>
      <address>
        <city>Butte</city>
        <state>Montana</state>
        <zip>59701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2014</study_first_submitted>
  <study_first_submitted_qc>November 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2014</study_first_posted>
  <last_update_submitted>December 5, 2015</last_update_submitted>
  <last_update_submitted_qc>December 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 3, 2016</submitted>
    <returned>March 2, 2016</returned>
    <submitted>March 23, 2016</submitted>
    <returned>April 25, 2016</returned>
    <submitted>June 1, 2016</submitted>
    <returned>July 12, 2016</returned>
    <submitted>September 23, 2016</submitted>
    <returned>November 10, 2016</returned>
    <submitted>November 14, 2016</submitted>
    <returned>January 10, 2017</returned>
    <submitted>July 19, 2017</submitted>
    <returned>August 21, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

